ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 484,29
0,95%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Cue Biopharma Inc (CUE)

  7. Cue Biopharma Inc (CUE) Actualités

CUE Cue Biopharma Inc

2,13
0,25 (13,30%)
04 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Cue Biopharma Inc CUE NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,25 13,30% 2,13 00:10:12
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
1,90 1,87 2,19 2,13 1,88
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
24/4/202416:01GLOBECue Biopharma to Present at the 2024 American Society of..
08/4/202422:05GLOBECue Biopharma Reports Fourth Quarter and Full Year 2023..
02/4/202414:00GLOBECue Biopharma to Host Business Update Call and Webcast
08/3/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/3/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202416:00GLOBECue Biopharma’s Lead Clinical Asset, CUE-101, to be Featured..
22/2/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202414:00GLOBECue Biopharma to Present Corporate Update at the..
04/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/1/202422:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/11/202314:00GLOBECue Biopharma to Present at the JMP Securities Hematology..
09/11/202322:05GLOBECue Biopharma Reports Third Quarter 2023 Financial Results..
07/11/202314:00GLOBECue Biopharma to Present at Three Upcoming Investor..
03/11/202321:15EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/11/202317:00GLOBECue Biopharma Presents New Positive Data from Phase 1 Trials..
02/11/202313:00GLOBECue Biopharma to Host Business Update Call and Webcast
27/9/202315:05GLOBECue Biopharma Announces Upcoming Scientific Presentations at..
26/9/202314:00GLOBECue Biopharma Announces Completion of Patient Enrollment in..
14/9/202322:01EDGAR2Form 8-K - Current report
29/8/202322:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/8/202322:10GLOBECue Biopharma Reports Second Quarter 2023 Financial Results..
08/8/202322:04EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202314:00GLOBECue Biopharma to Host Business Update Call and Webcast
25/7/202318:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202318:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202318:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/7/202318:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/6/202314:00GLOBECue Biopharma to Present at the Federation of Clinical..
07/6/202314:00GLOBECue Biopharma to Host Investor Call
05/6/202314:00GLOBECue Biopharma to Present at the Jefferies 2023 Global..
25/5/202323:00GLOBECue Biopharma Presents Positive Data Update from Ongoing..
15/5/202314:00GLOBECue Biopharma to Present at the 2023 American Society of..
09/5/202322:35GLOBECue Biopharma Reports First Quarter 2023 Financial Results..
08/5/202314:00GLOBECue Biopharma to Present at the Upcoming JMP Securities Life..

Dernières Valeurs Consultées

NASDAQ
CUE
Cue Biopharma
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés